Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119149752 | 11914975 | 2 | F | 20151223 | 20160715 | 20160113 | 20160725 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093029 | BRISTOL MYERS SQUIBB | 90.01 | YR | F | Y | 0.00000 | 20160725 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119149752 | 11914975 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 1 UNIT, PRN | Y | 9218 | 1 | DF | TABLET | ||||||
| 119149752 | 11914975 | 2 | I | BORAGE OIL | BORAGE OIL | 1 | Oral | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119149752 | 11914975 | 1 | Atrial fibrillation |
| 119149752 | 11914975 | 2 | Stomatitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119149752 | 11914975 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119149752 | 11914975 | Drug interaction | |
| 119149752 | 11914975 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119149752 | 11914975 | 2 | 20151216 | 0 |